Albert Einstein College of Medicine - Company Focused Market Research Report
Company Overview
- Name: Albert Einstein College of Medicine
- Mission of the Company: To educate students to become caring physicians and world-class scientists and to foster pioneering programs in biomedical and translational research that will lead to better healthcare and reduced health disparities.
- When was the Company Founded and by Whom: Founded in 1955 after an agreement with Professor Albert Einstein to lend his name to the institution.
- Key People in the Company:
- Yaron Tomer, M.D., Marilyn and Stanley M. Katz Dean
- Philip O. Ozuah, MD, PhD, President and CEO of Montefiore Medicine
- Teresa Bowman, Ph.D., Chair of Developmental & Molecular Biology
- Where is the Company Headquartered: Bronx, NY, at Jack and Pearl Resnick Campus, 1300 Morris Park Avenue.
- Number of Employees: Over 53,000 within Montefiore Health System, which includes the College of Medicine.
- Revenue of the Company: No information is available.
- What is the Company Known For: Albert Einstein College of Medicine is a premier center for research, medical education, and clinical investigation, known for its commitment to health equity and social justice.
Products
- What products do they offer:
- Academic programs including MD Program, PhD Program, MD/PhD Program, and Postdoctoral Studies
- Research initiatives spanning numerous biomedical fields
- Clinical services in partnership with Montefiore Health System
- High-level Description of the Product:
- Academic programs develop knowledgeable and compassionate physicians and innovative scientific investigators.
- Research initiatives seek to accelerate the pace of scientific discovery and translate findings into healthcare improvements.
- Clinical services are provided through a highly integrated system alongside Montefiore, focused on advanced diagnostics and innovative care.
- Key Features of Each Product:
- Programs emphasize a diverse and inclusive approach, intending to improve diversity in the medical field.
- Extensive research faculties resulting in NIH funding of over $200 million.
- Montefiore Einstein proves critical care across more than 300 locations and specialty services meeting complex medical needs.
Recent Developments
- What Are the Recent Developments in the Company:
- Establishment of the Marilyn and Stanley M. Katz Institute for Immunotherapy for Cancer and Inflammatory Disorders.
- Teresa Bowman, Ph.D., named Chair of Developmental & Molecular Biology.
- Launch of a new Immunotherapy Institute to push forward in cancer and inflammatory disorder treatment research.
- What Are the New Products Launched:
- The new institute for Immunotherapy focusing on the Carolinas with innovative research and clinical trials.
- What Are the New Features Added to the Existing Products:
- Enhanced focus on developing novel immunotherapy technologies and advancing clinical trials.
- Any New Partnerships Etc:
- Integrated efforts with philanthropic contributions like the $4.5M endowment by Marilyn and Stanley Katz to support Immunotherapy progress.
- Establishment of free tuition for all medical students as supported by a transformational gift from Ruth L. Gottesman.
The Albert Einstein College of Medicine through its rich history and recent expansions, continues to be at the forefront of medical education and research, dedicated to fostering the next generation of medical and scientific leaders while advancing public healthcare.